REQUEST A DEMO
Total
USD $0.00
Search more companies

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Walvax Biotechnology Co.,Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) is based in China. The head office is in Yuxi. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on January 16, 2001. Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) currently employs 1,932 (2024) people. The latest financial highlights indicate a net sales revenue drop of 14.29% in 2025. Its total assets decreased by 18.02% over the same period. The net profit margin of Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) decreased by 1% in 2025.

Headquarters
No. 395, Kexin Road, High-tech Zone, Kunming City, Yunnan Province
Yuxi; Yunnan; Postal Code: 650101

Contact Details: Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.

Website: http://www.walvax.com

Basic Information
Total Employees:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Registered Capital:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Financial Auditors:
Purchase the Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report to view the information.
Incorporation Date:
January 16, 2001
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
2.16%
Purchase this report to view the information.
1.81%
Purchase this report to view the information.
1.7%
Purchase this report to view the information.
1.56%
Purchase this report to view the information.
1.48%
Subsidiaries
Beijing Watson Innovation Biotechnology Co., Ltd.
100%
Beijing Weida Biotechnology Co., Ltd.
100%
Guangdong Watson Pharmaceutical Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-14.29%
Total Operating Revenue
-10.18%
Operating Profit
94.42%
Net Profit/Loss for the Period
-28.23%
Total Assets
-18.02%
Total Equity
-17.13%
Operating Profit Margin
4.34%
Net Profit Margin
-1%
Return on Equity (ROE)
-0.21%
Debt / Equity
-0.07%
Quick Ratio
-0.61%
Cash Ratio
-0.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?